- Corporate Officers - C
- Chaudhuri Bhaskar
Insider Trading History of Chaudhuri Bhaskar
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chaudhuri Bhaskar since 2009.
This trader's CIK number is 1458643.
At the time of last reporting, Chaudhuri Bhaskar was the Director of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS).
Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..
Note that in the past
CHAUDHURI BHASKAR also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Valeant Pharmaceuticals International (VRX) by Chaudhuri Bhaskar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | VRX | 19,728 | $500,091 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arcutis Biotherapeutics, Inc. (ARQT) by Chaudhuri Bhaskar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ARQT | 0 | $0 | 60,000 | $1,832,395 | 0 | $0 |
Yearly summary of insider trading at Teligent, Inc. (TLGT) by Chaudhuri Bhaskar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | TLGT | 10,000 | $7,010 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tarsus Pharmaceuticals, Inc. (TARS) by Chaudhuri Bhaskar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TARS | 0 | $0 | 0 | $0 | 3,350 | $0 |
| 2023 | TARS | 0 | $0 | 0 | $0 | 2,000 | $0 |
Insider trading activities at 4 companies by Chaudhuri Bhaskar:
1. Valeant Pharmaceuticals International (VRX)
2. Arcutis Biotherapeutics, Inc. (ARQT)
3. Teligent, Inc. (TLGT)
4. Tarsus Pharmaceuticals, Inc. (TARS)
Table 1. Insider trading of Valeant Pharmaceuticals International (VRX) by Chaudhuri Bhaskar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-11-20 | VRX | Buy | 3,000 | 33.31 | 99,926 |
| 2009-11-18 | VRX | Buy | 2,385 | 33.58 | 80,097 |
| 2009-11-10 | VRX | Buy | 1,525 | 32.81 | 50,039 |
| 2009-08-14 | VRX | Buy | 3,373 | 26.69 | 90,025 |
| 2009-05-26 | VRX | Buy | 1,352 | 22.19 | 30,000 |
| 2009-05-18 | VRX | Buy | 1,360 | 22.06 | 30,001 |
| 2009-05-11 | VRX | Buy | 1,538 | 19.50 | 29,991 |
| 2009-05-04 | VRX | Buy | 1,760 | 17.05 | 30,008 |
| 2009-04-27 | VRX | Buy | 1,732 | 17.32 | 29,998 |
| 2009-04-20 | VRX | Buy | 1,703 | 17.62 | 30,006 |
Table 2. Insider trading of Arcutis Biotherapeutics, Inc. (ARQT) by Chaudhuri Bhaskar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-24 | ARQT | Sale | 729 | 27.50 | 20,047 |
| 2021-06-25 | ARQT | Sale | 6,755 | 27.50 | 185,762 |
| 2021-06-21 | ARQT | Sale | 2,516 | 27.50 | 69,190 |
| 2021-06-01 | ARQT | Sale | 10,000 | 27.50 | 275,000 |
| 2021-04-20 | ARQT | Sale | 10,000 | 28.26 | 282,580 |
| 2021-03-22 | ARQT | Sale | 10,000 | 31.10 | 311,030 |
| 2021-02-22 | ARQT | Sale | 10,000 | 35.66 | 356,580 |
| 2021-02-01 | ARQT | Sale | 9,949 | 33.25 | 330,804 |
| 2021-01-29 | ARQT | Sale | 51 | 27.50 | 1,402 |
Table 3. Insider trading of Teligent, Inc. (TLGT) by Chaudhuri Bhaskar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-03 | TLGT | Buy | 10,000 | .70 | 7,010 |
Table 4. Insider trading of Tarsus Pharmaceuticals, Inc. (TARS) by Chaudhuri Bhaskar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-24 | TARS | Option Ex | 3,350 | .00 | 0 |
| 2023-06-16 | TARS | Option Ex | 2,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Chaudhuri Bhaskar
(Director of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.